GlassScriptPhysician profile
Alisa L Walker
NPI 1922668896
$830.00
in general payments reported to CMS, 2019-2025
11 companies · $799 in 2025
The $799 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $31.13 · 2025: $799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $830.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $391.43 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Abbvie INC. | $75.30 | 2025 | |
| Braeburn INC. | $71.11 | 2025 | Brixadi |
| Virtus Pharmaceuticals LLC | $57.75 | 2025 | Levorphanol Tartrate |
| Scilex Pharmaceuticals INC. | $53.19 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.70 | 2025 | Relistor, Trulance |
| Indivior INC. | $39.15 | 2025 | Sublocade |
| Azurity Pharmaceuticals, INC. | $38.74 | 2025 | Horizant |
| Valinor Pharma, LLC | $21.31 | 2025 | Movantik |
| Collegium Pharmaceutical, INC. | $21.22 | 2025 | Belbuca |
| Alkermes, INC. | $17.10 | 2025 | Vivitrol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alisa Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.